The Association of Clinical Research Professionals (ACRP) is pleased to announce that the following individuals have been elected by the ACRP membership to serve on the Association's Board of Trustees for 2024.
Health Care Compliance Association®(HCCA®) invites you to join us for our 28th Annual Compliance Institute, April 14–17 2024, where you can connect with other healthcare professionals and get the latest information and updates on healthcare compliance priorities and best practices.
While the U.S. Department of Justice continues to prioritize its investigation of fraud and misconduct within the clinical research space, the Office of Research Integrity (ORI)-Department of Health and Human Services (HHS) recently released its Final Rule on regulations governing Public Health Service Policies on Research Misconduct, which takes effect January 1, 2025. Clearly, the role of compliance in clinical research is a critical area of focus, one with the potential for significant consequences if overlooked or minimized.
Eighty-five percent of trials fail to recruit enough patients, while 80% are delayed due to other factors like participant dropouts. These high rates are influenced by financial, emotional, and logistical barriers to participation, such as geographic location and travel-related costs, which prevent patients from enrolling in trials and accessing life-changing medicine. As 2024 gets under way, clinical trial stakeholders are witnessing transformative trends aimed at addressing these pain points.
When the ACRP 2024 pre-conference events get under way in Anaheim, Calif., in May, retiree John P. Rowell, Jr., MSN, will take a break from his home gardening and competitive sport shooting to once again present a day-long Friday workshop aimed at helping new clinical researchers face the many workforce-related challenges being thrown at them, as he has for nearly 25 years, this time teamed up with several colleagues.